Supernus Pharmaceuticals (SUPN) executive compensation, 2026 proxy

Jack A. Khattar, Chief Executive Officer, President & Secretary, was paid $15.5M in 2025, up 23% from $12.6M the year before. The CEO-to-median-employee pay ratio was 81:1, on median employee pay of $192,397.

Filed
April 30, 2026
Annual meeting
June 18, 2026
Pay year
2025
Named executives
5
CEO total pay
$15.5M+23% vs prior year
CEO to median employee
81:1median $192,397
CEO pay in equity
88%$13.6M in awards
Prior say-on-pay support
96%of votes cast
CEO Total Compensation
$15.5MFor fiscal year 2025
CEO Pay Ratio
81:1Compared to median employee
Median Employee Pay
$192,397Annual total compensation
Say on Pay Support
96%Previous stockholder approval

How Khattar was paid

$15.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary7%Stock awards42%Option awards45%Non-equity incentive5%All other compensation0%

Named executive officers

ExecutiveTotal
Jack A. KhattarChief Executive Officer, President & Secretary$15,501,557
Timothy C. DecSenior Vice President, Chief Financial Officer$1,916,409
Jonathan Rubin, MDSenior Vice President, Chief Medical Officer Research and Development$1,448,731
Padmanabh P. Bhatt, Ph.D.Senior Vice President, Intellectual Property, Chief Scientific Officer$1,391,429
Frank MottolaSenior Vice President, Chief Technical Operations Officer$1,360,701

What changed and why

  • $15.5MCEO total compensation increased to $15,501,557 in fiscal 2025.
  • 96%Stockholders voted overwhelmingly in favor of executive compensation with more than 96% support.
  • CEO performance is measured directly against corporate objectives and financial metrics.
  • Independent compensation consultant Aon reviewed executive compensation programs to ensure alignment.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.